Diltiazem STELLA 60 mg

Diltiazem is a benzothiazepine calcium-channel blocking agent. It increases exercise capacity and improves all indices of myocardial ischaemia in the angina patient.



Pack size Box of 30 tablets; Bottle of 100 tablets
Shelf-life 48 months
Composition Diltiazem hydrochloride
Dosage forms and strengths Tablet: 60 mg
Product code :



  • Prophylaxis and treatment of angina pectoris.


  • Adults
    The usual dose is 1 tablet three times daily. If necessary the divided dose may be increased to 6 tablets daily. Higher doses up to 8 tablets daily have been used with benefit in some patients especially in unstable angina.
  • Elderly and patients with impaired hepatic or renal function
    The starting dose is one tablet twice daily. The dose should not be increased if the heart rate falls below 50 beats per minute.
  • Diltiazem is not recommended for use in children.


  • Administered orally.
  • It should be taken with a glass of water before meals, swallowed the whole tablet, should not be chewed, broken, crushed.
  • Known hypersensitivity to any of the active substance or excipients.
  • Sinus dysfunction.
  • 2nd and 3rd degree atrioventricular block.
  • Left ventricular failure with pulmonary stasis.
  • Severe bradycardia (less than 50 beats per minute)
  • Lactation.
  • Concurrent use with dantrolene infusion
  • Combination with ivabradine
  • Patients with severe hypotension (less than 90 mmHg systolic)
  • Patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.
  • Peripheral oedema.
  • Headache, dizziness.
  • Atrioventricular block, palpitations.
  • Flushing.
  • Constipation, dyspepsia, gastric pain, nausea.
  • Erythema, Malaise.
  • Use with caution in patients with reduced left ventricular function, bradycardia or with a 1st degree AV block or prolonged PR interval detected on the electrocardiogram; in patients at risk of developing an intestinal obstruction; patients with latent or manifest due to a possible increase in blood glucose.
  • Drug discontinuation should be considered if mood changes, including depression.
  • Diltiazem is not recommended during pregnancy, as well as in women of child-bearing potential not using effective contraception. Breastfeeding is not recommended during drug administration.
  • Patients should be aware of how they react to drug before driving or operating machinery.